Mesenchymal Cell News Volume 13.07 | Feb 23 2021

    0
    45







    Subject


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 13.07 – 23 February, 2021
    TOP STORY

    Complement Activation Promoted by the Lectin Pathway Mediates C3aR-Dependent Sarcoma Progression and Immunosuppression

    Scientists conducted a systematic assessment of the role of complement activation and effector pathways in sarcomas. Mice showed reduced susceptibility to 3-methylcholanthrene sarcomagenesis and transplanted sarcomas, whereas C1q and factor B deficiency had marginal effects.
    [Nature Cancer]

    Abstract

    Virtual Conference Exhibition: Pluripotent Stem Cells
    PUBLICATIONSRanked by the impact factor of the journal

    Depletion of H3K36me2 Recapitulates Epigenomic and Phenotypic Changes Induced by the H3.3K36M Oncohistone Mutation

    Researchers specifically depleted H3K36me2 or H3K36me3 in mesenchymal cells, using CRISPR-Cas9 to separately knock out the corresponding methyltransferases NSD1/2 or SETD2.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    GBP5 Drives Malignancy of Glioblastoma via the Src/ERK1/2/MMP3 Pathway

    Investigators showed that GBP5 was highly expressed in glioblastoma cell lines and in clinical samples, especially in the mesenchymal subtype.
    [Cell Death & Disease]

    Full Article

    Elavl1 Impacts Osteogenic Differentiation and mRNA Levels of Genes Involved in ECM Organization

    Biological functions of Elavl1 during osteogenic differentiation of bone marrow derived MSCs (BMSCs) is not well-understood. The authors report that specific knockdown of nuclear localized Elavl1 by RNA interference in multipotent BMSCs led to increased osteogenic differentiation.
    [Frontiers in Cell and Developmental Biology]

    Full Article

    Human Umbilical Cord Mesenchymal Stem Cells Attenuate Podocyte Injury under High Glucose via TLR2 and TLR4 Signaling

    Scientists investigated the effects of high glucose on the innate immunity of podocytes and diabetic nephropathy mice via Toll like receptor (TLR) signaling, and explored the protective effects of human umbilical cord-MSCs on this process.
    [Diabetes Research and Clinical Practice]

    Full Article

    Promotive Role of CircATRNL1 on Chondrogenic Differentiation of BMSCs Mediated by miR-338-3p

    The effects of circATRNL1 (hsa_circ_0020093) on the differentiation of bone marrow MSCs into chondrocytes were investigated.
    [Archives of Medical Research]

    Full Article

    Moringa oleifera Leaf Extracts Protect BMSC Osteogenic Induction Following Peroxidative Damage by Activating the PI3K/Akt/Foxo1 Pathway

    Researchers investigated the therapeutic effects of Moringa oleifera leaf extracts on osteogenic induction of rat bone marrow MSCs following peroxidative damage and to explore the underlying mechanisms.
    [Journal of Orthopaedic Surgery and Research]

    Full Article

    Early Systemic Immune Biomarkers Predict Bone Regeneration after Trauma

    In a preclinical model of orthopedic trauma, scientists demonstrated that distinct systemic immune profiles were correlated with impaired bone regeneration. Most notably, elevated blood levels of myeloid-derived suppressor cells and the immunosuppressive cytokine interleukin-10 were negatively correlated with functional bone regeneration as early as 1 week post-treatment.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    BMP2-Dependent Gene Regulatory Network Analysis Reveals Klf4 as a Novel Transcription Factor of Osteoblast Differentiation

    The BMP signaling pathway is widely regarded as one of the most important pathways in vertebrate skeletal biology, of which BMP2 is a potent inducer, governing the osteoblast differentiation of bone marrow stromal cells. Researchers used RNA-seq, ATAC-seq, and animal models to characterize the BMP2-dependent gene regulatory network governing osteoblast lineage commitment.
    [Cell Death & Disease]

    Full Article

    Stiffness Increases with Myofibroblast Content and Collagen Density in Mesenchymal High Grade Serous Ovarian Cancer

    Investigators suggested that tumor stiffness could be at the crossroad of three major processes, i.e. matrix remodeling, MEK activation and stromal metabolic switch that might explain at least in part Mesenchymal high-grade serous ovarian cancers aggressiveness.
    [Scientific Reports]

    Full Article

    Dr. Fabio Rossi discusses the role of mesenchymal stem cells in tissue repair and development.
    REVIEWS

    Efficacy of Complementary Treatment with Autologous Platelet Concentrates and/or Mesenchymal Stem Cells in Chemical Osteonecrosis of the Jaw

    The authors find out what scientific evidence is available on the use of autologous plasma concentrates and MSCs as complementary therapies at the management of Medication-related Osteonecrosis of the jaw.
    [Journal of Stomatology, Oral and Maxillofacial Surgery]

    Abstract

    INDUSTRY AND POLICY NEWS

    Positive Outcomes of First Children Treated with Remestemcel-L for Multisystem Inflammatory Syndrome (MIS-C) and Heart Failure Post-COVID-19

    Mesoblast Limited has treated the first two children with their MSC product candidate remestemcel-L for life-threatening MIS-C associated with COVID-19. MIS-C, a potentially life-threatening inflammatory condition which involves multiple critical organs and their vasculature, is associated with prior rather than active COVID-19 infection.
    [Mesoblast, Ltd.]

    Press Release

    FEATURED EVENT

    Congress of the European Hematology Association – EHA2021 Virtual

    June 9 – 17, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Researcher – Gene-Modified Stem Cells

    National University of Ireland Galway – Galway, Ireland

    Research Assistant – Melanoma Research

    Portland VA Research Foundation – Portland, Oregon, United States

    Postdoctoral Position – Osteoporosis

    University of Southern Denmark – Odense M, Denmark

    Postdoctoral Researcher – Mesenchymal Niche in Leukemia

    Karolinska Institutet – Flemingsberg, Sweden

    Postdoctoral Fellow – Osteoarthritis

    Oklahoma Medical Research Foundation – Oklahoma City, Oklahoma, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mesenchymal Cell News Twitter